Literature DB >> 28532100

The controlled drug release by pH-sensitive molecularly imprinted nanospheres for enhanced antibacterial activity.

Congyang Mao1, Xianzhou Xie1, Xiangmei Liu1, Zhenduo Cui2, Xianjin Yang2, K W K Yeung3, Haobo Pan4, Paul K Chu5, Shuilin Wu6.   

Abstract

In this study, we prepared pH-sensitive hybrid nanospheres through the implementation of a facile molecularly imprinted polymer (MIP) technique combined with a UV-initiated precipitation polymerization method using vancomycin (VA) for the templates. During the course of this investigation, both 2-hydroxyethyl methacrylate (HEMA) and 2-(diethylamino) ethyl methacrylate (DEAEMA) were utilized as the functional monomers, while ethylene glycol dimethacrylate (EGDMA) was used as a cross-linker. The obtained MIP nanospheres exhibited well-controlled particle size, with a drug loading capacity of about 17%, much higher than that of the non-imprinted polymer (NIP) nanospheres (5%). In addition, the VA loading quantity was closely correlated with the dosage of the cross-linking agent, and the MIP nanospheres exhibited a slower and more controlled VA release rate than the NIP nanospheres. Moreover, these MIP nanospheres were sensitive to pH values, and consequently showed an increasing release rate of VA as the pH level was decreased. The VA-loaded MIP nanospheres showed the higher antibacterial ratio of over 92% against Staphylococcus aureus (S. aureus) while the NIP nanospheres were friendly to S. aureus. These MIP nanospheres can be promising for targeting drug delivery system to achieve specific therapies such as preventing bacterial infections and killing cancer cells without damaging health cells and tissues.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antibacterial; Drug delivery; Molecularly imprinted nanospheres; Polymerization; pH-sensitive

Mesh:

Substances:

Year:  2017        PMID: 28532100     DOI: 10.1016/j.msec.2017.03.259

Source DB:  PubMed          Journal:  Mater Sci Eng C Mater Biol Appl        ISSN: 0928-4931            Impact factor:   7.328


  7 in total

1.  Mechanism Investigation of Hyaluronidase-Combined Multistage Nanoparticles for Solid Tumor Penetration and Antitumor Effect.

Authors:  Enrui Chen; Shangcong Han; Bo Song; Lisa Xu; Haicheng Yuan; Mingtao Liang; Yong Sun
Journal:  Int J Nanomedicine       Date:  2020-08-24

2.  Application of a Physiologically Based Pharmacokinetic Model to Develop a Veterinary Amorphous Enrofloxacin Solid Dispersion.

Authors:  Kaixiang Zhou; Meixia Huo; Wenjin Ma; Kun Mi; Xiangyue Xu; Samah Attia Algharib; Shuyu Xie; Lingli Huang
Journal:  Pharmaceutics       Date:  2021-04-22       Impact factor: 6.321

Review 3.  Microsphere Polymers in Molecular Imprinting: Current and Future Perspectives.

Authors:  Tirza Ecclesia Orowitz; Patria Pari Agnes Ago Ana Sombo; Driyanti Rahayu; Aliya Nur Hasanah
Journal:  Molecules       Date:  2020-07-17       Impact factor: 4.411

4.  Solid lipid nanoparticles with enteric coating for improving stability, palatability, and oral bioavailability of enrofloxacin.

Authors:  Chao Li; Kaixiang Zhou; Dongmei Chen; Wei Xu; Yanfei Tao; Yuanhu Pan; Kuiyu Meng; Muhammad Abu Bakr Shabbir; Qianying Liu; Lingli Huang; Shuyu Xie
Journal:  Int J Nanomedicine       Date:  2019-03-01

Review 5.  A review on nanosystems as an effective approach against infections of Staphylococcus aureus.

Authors:  Kaixiang Zhou; Chao Li; Dongmei Chen; Yuanhu Pan; Yanfei Tao; Wei Qu; Zhenli Liu; Xiaofang Wang; Shuyu Xie
Journal:  Int J Nanomedicine       Date:  2018-11-09

6.  Development of Water-Compatible Molecularly Imprinted Polymers Based on Functionalized β-Cyclodextrin for Controlled Release of Atropine.

Authors:  Yahui He; Shaomei Zeng; A M Abd El-Aty; Ahmet Hacımüftüoğlu; Woldemariam Kalekristos Yohannes; Majid Khan; Yongxin She
Journal:  Polymers (Basel)       Date:  2020-01-06       Impact factor: 4.329

Review 7.  Progress Report: Antimicrobial Drug Discovery in the Resistance Era.

Authors:  Pottathil Shinu; Abdulaziz K Al Mouslem; Anroop B Nair; Katharigatta N Venugopala; Mahesh Attimarad; Varsha A Singh; Sreeharsha Nagaraja; Ghallab Alotaibi; Pran Kishore Deb
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.